SCHEMBL7635697

SCHEMBL7635697

CCC=CCCCCCCCCCCCCCCCC(=O)O

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.89
F7 P08709 6/20 0.89
F3 P13726 6/20 0.89
PPARG P37231 6/20 0.89
PPARD Q03181 6/20 0.89
PPARA Q07869 6/20 0.89
CYP19A1 P11511 5/20 0.89
MAPT P10636 4/20 0.89
HSD17B10 Q99714 4/20 0.89
PTGS1 P23219 4/20 0.89
BLM P54132 3/20 0.89
KMT2A Q03164 3/20 0.89
LMNA P02545 3/20 0.89
ALOX15 P16050 3/20 0.89
TDP1 Q9NUW8 3/20 0.89
RECQL P46063 2/20 0.89
OXER1 Q8TDS5 2/20 0.89
KDM4E B2RXH2 2/20 0.89
FFAR1 O14842 2/20 0.89
CYP3A4 P08684 2/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8020062 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL2941427 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL2318370 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL1655437 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL2574583 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL8005040 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL25326380 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL4333112 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL10715420 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD
SCHEMBL371618 1.00 ALDH1A1 (0.89) ALDH1A1F7F3PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116440112-A Anti-inflammatory agent containing rare fatty acid 国立大学法人京都大学 2023-07-18 CN claimed
WO-2025090914-A1 CARBOXYLIC ACID REDUCTASE VARIANTS AND METHODS OF USE GENOMATICA, INC. (US) 2025-05-01 WO disclosed
CN-117157049-A ATP synthase inhibitor-cosmetic and therapeutic use 迈克尔·大卫·福雷斯特 2023-12-01 CN disclosed
CN-116440112-A Anti-inflammatory agent containing rare fatty acid 国立大学法人京都大学 2023-07-18 CN disclosed
CN-113271917-B Hair care and conditioning compositions 莱雅公司 2023-07-07 CN disclosed
CN-115607677-A Compound for preventing, preventing or treating microbial infection and preparation and application thereof 太阳雨林(北京)生物医药有限公司 2023-01-17 CN disclosed
CN-114569726-B Compound for preventing, preventing or treating microbial infection and preparation method and application thereof 太阳雨林(北京)生物医药有限公司 2022-10-28 CN disclosed
CN-114788872-A Compound for preventing, preventing or treating microbial infection and preparation and application thereof 太阳雨林(北京)生物医药有限公司 2022-07-26 CN disclosed
CN-114569726-A Compound for preventing, preventing or treating microbial infection and preparation method and application thereof 太阳雨林(北京)生物医药有限公司 2022-06-03 CN disclosed
US-6342619-B2 REACTING FATTY ACID ESTER HAVING SEGMENT IN WHICH CARBON ONE BEARS HYDROXYL GROUP, CARBON TWO BEARS TWO HYDROGE N ATOMS AND DOUBLE BOND IS BETWEEN CARBONS THREE AND FOUR, WIT H ALKYL OR ARYLSULFONYL CHLORIDE, REACTING WITH DIAZABICYCLOU NDECENE BOEHRINGER INGELHEIM VETMEDICA, INC. 2002-01-29 US disclosed
US-20010049451-A1 Synthesis of conjugated fatty acid BOEHRINGER INGELHEIM VETMEDICA, INC. 2001-12-06 US disclosed
US-6160141-A Synthesis of conjugated eicosadienoic acid MATREYA, INC. 2000-12-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010049451-A1 Synthesis of conjugated fatty acid FASN, LIPC, FADS1 ALDH1A1 2564/4885F7 3328/4885F3 2797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.